Clinical Trial Update: T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and Adolescents [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated adding T-20 (enfuvirtide) to a selected anti-HIV regimen in HIV-infected children and adolescents; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• T-20 (enfuvirtide)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: HIV Infections | Phase 2 | Status: COMPLETED | Results posted: 2016-02-15